Part 4 of our Bridging the Gap Series (Summary of the webinar session held in March 2024) In the rapidly evolving landscape of cell and gene therapy, stakeholders from across the industry are coming together to envision the future of these groundbreaking treatments. Recently, a panel of experts engaged in a thought-provoking discussion as part of the Bridging […]
View Blog
Part 3 of our Bridging the Gap Series (Summary of the webinar session held in February 2024) Gene therapy has emerged as a promising frontier in modern medicine, offering revolutionary treatments for a range of diseases previously considered incurable. In a recent webinar as part of the Bridging the Gap series, guest speaker Dr. Bruce Levine, a cancer […]
View Blog
Part 2 of our Bridging the Gap Series (Summary of the webinar session held in December 2023) As the cell therapy industry continues to expand, one organization is leading the way in advanced therapies, ensuring that hospital programs for cell treatments, such as CAR T-cell therapy, follow rigorous protocols and measure outcomes. This group, the Foundation for the […]
View Blog
Part 1 of our Bridging the Gap Series (Summary of the webinar session held in November 2023) Azenta and The Emily Whitehead Foundation have joined forces to launch an impactful new webinar series titled “Bridging the Gap.” The series aims to establish connections between scientific advancements, the biotechnology industry, and patient care, with the ultimate goal of […]
View Blog
In today’s fast-paced and demanding scientific and technological landscape, laboratories and research facilities heavily rely on complex instruments and equipment to carry out their work efficiently. These instruments, ranging from analytical devices to automated cryogenic storage systems, are essential for storing valuable samples, completing analysis, managing data, and running experiments. However, to ensure smooth operations […]
View Blog
Azenta Launches CryoArc™ Pico at SLAS2023 Many cell and gene therapies today rely on cryostorage with precise cold chain handling to ensure the viability and effectiveness of the cells that deliver life-saving treatments. But accessing these cell therapies can sometimes be a cumbersome process for labs and clinics that don’t have the space needed to […]
View Blog
Part 2 of our Protecting Complete Chain of Custody Series As we discussed in our last post, the Role of Biobanking in Protecting Sample Chain of Custody, biobanks serve as biospecimen libraries as well as sample data, validation, and reference sources for both research and clinical labs. Like any part of a controlled process, establishment of a quality […]
View Blog
Part 1 of our Protecting Complete Chain of Custody Series As key components of the research ecosystem, biobanks share a vital function and critical responsibility in the protection of biospecimens. They are centralized members in the chain of custody for samples, and as such, have an impact on both upstream and downstream portions of the molecular biologist’s […]
View Blog
As cell and gene therapies (CGT) advance into the clinical stage, many cold chain complexities arise not only for these novel products but also for the biological samples that must be collected from patients during clinical trials. Managing these sensitive materials—including storage, transportation, and tracking—requires robust and adaptable systems to ensure safety, integrity, and regulatory […]
View Blog
Informed consent is a legal and ethical requirement of all clinical research. While specific patient consent guidelines differ around the world1, all conform to the Declaration of Helsinki’s principles of protecting patients involved in clinical research2. Using broad, generic or tiered consent will allow researchers to reuse patient samples in future studies. Many funding agencies, such as […]
View Blog